Reverse vaccinology and immunoinformatic approach for designing a bivalent vaccine candidate against hepatitis A and hepatitis B viruses
N Ahmadi, M Aghasadeghi, M Hamidi-Fard… - Molecular …, 2023 - Springer
Hepatitis A and B are two crucial viral infections that still dramatically affect public health
worldwide. Hepatitis A Virus (HAV) is the main cause of acute hepatitis, whereas Hepatitis B …
worldwide. Hepatitis A Virus (HAV) is the main cause of acute hepatitis, whereas Hepatitis B …
[HTML][HTML] The Seroprevalence of Hepatitis A in Patients with Positive Human Immunodeficiency Virus
N Omidifar, KB Lankarani, MBA Ghadim… - Middle East Journal …, 2023 - ncbi.nlm.nih.gov
Background: Hepatitis A virus (HAV) can have severe manifestations in adult patients with
other liver diseases, particularly in those infected with human immunodeficiency virus (HIV) …
other liver diseases, particularly in those infected with human immunodeficiency virus (HIV) …
[HTML][HTML] Hepatitis A Chronic Immunity in Iran: A Geographic Information System-Based Study
Background: Chronic immunity to hepatitis A (HA) is largely influenced by environmental
factors, such as socioeconomic indicators, public health conditions, and access to safe …
factors, such as socioeconomic indicators, public health conditions, and access to safe …
[HTML][HTML] Status of immunity against the hepatitis a virus in healthy population: A report from Southeastern Iran
A Bakhshipour, N Sargolzaie… - Archives of Clinical …, 2021 - brieflands.com
Background: Recently, epidemiological studies on hepatitis A virus (HAV) infection showed
the seroprevalence has been changing due to changes in lifestyle. To the best of our …
the seroprevalence has been changing due to changes in lifestyle. To the best of our …
[HTML][HTML] Iranian consensus guideline for pharmacotherapy with biologics and small molecules drugs in adults with inflammatory bowel diseases
N Khoshnam-Rad, H Vahedi, A Sadeghi… - Middle East Journal …, 2023 - ncbi.nlm.nih.gov
Background: Pharmacotherapy with biologics and small molecules, as the more effective
therapies for moderate to severe ulcerative colitis (UC) and Crohn's disease (CD), is …
therapies for moderate to severe ulcerative colitis (UC) and Crohn's disease (CD), is …
[PDF][PDF] Hepatitis A Chronic Immunity: A Population-Based Seroprevalence Study in Fars Province, Southern Iran
B Honarvar, MH Zahedroozegar, N Asmarian… - Hepatitis …, 2021 - brieflands.com
Background: Hepatitis A virus (HAV), the most common cause of acute viral hepatitis, afflicts
millions of people and causes the loss of thousands of lives annually. Objectives: This study …
millions of people and causes the loss of thousands of lives annually. Objectives: This study …
Immunity to hepatitis A virus in liver transplant recipients: A population-based study in Iran
A Rashidi, F Sedaghat, A Nejat, N Azarpira… - Gastroenterología y …, 2022 - Elsevier
Background Acute hepatitis A is usually a self-limited viral disease but can be severe and
even fatal in special groups of patients including those with chronic liver disease and …
even fatal in special groups of patients including those with chronic liver disease and …
[PDF][PDF] Immunoglobulin G Immunity to Hepatitis A Virus in Liver Transplant Candidates: A Serosurvey from Iran
KB Lankarani, B Honarvar, MH Zahedroozegar… - Hepatitis …, 2021 - brieflands.com
Background: Becoming infected with hepatitis A virus (HAV) is deadlier in patients with end-
stage liver disease. Objectives: This study aimed to determine the seroprevalence of chronic …
stage liver disease. Objectives: This study aimed to determine the seroprevalence of chronic …
[PDF][PDF] Comparison of PCR with Serology for Detecting Acute Hepatitis A Virus Infection
Introduction: Early detection of acute Hepatitis A virus infection (HAV) allows adopting
proper treatment measures, rapid recovery, and avoiding side effects. This study compares …
proper treatment measures, rapid recovery, and avoiding side effects. This study compares …